Calidi Biotherapeutics, Inc. (CLDI) Financials

$0.23

$0 (0.74%)
Last update: 04:00 PM EST
Day's range
$0.23
Day's range
$0.24
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning20202020202120212022202220232023202420240%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%-60000%-60000%-70000%-70000%Profit Margin
Profit Margin
Revenue
Earnings

CLDI Income statement / Annual

Last year (2024), Calidi Biotherapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Calidi Biotherapeutics, Inc.'s net income was -$22.14 M. See Calidi Biotherapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $45.00 K $449.00 K $0.00
Cost of Revenue $1.54 M $1.26 M $274.00 K $94.00 K $0.00
Gross Profit $0.00 -$1.26 M -$229.00 K $355.00 K $0.00
Gross Profit Ratio 0 0 -5.09 0.79 0
Research and Development Expenses $8.88 M $13.01 M $7.26 M $4.67 M $3.18 M
General & Administrative Expenses $12.90 M $15.98 M $15.90 M $6.16 M $3.59 M
Selling & Marketing Expenses $0.00 $0.00 -$260.00 K -$4.38 M $0.00
Selling, General & Administrative Expenses $12.90 M $15.98 M $15.64 M $1.78 M $3.59 M
Other Expenses $0.00 $0.00 -$5.00 K $9.00 K $4.00 K
Operating Expenses $21.78 M $28.99 M $22.90 M $1.78 M $6.77 M
Cost And Expenses -$21.78 M $28.99 M $23.17 M $1.78 M $6.77 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $933.00 K $1.07 M $158.00 K $614.00 K $163.00 K
Depreciation & Amortization $791.00 K $1.26 M $260.00 K $153.00 K $117.00 K
EBITDA -$21.78 M -$27.58 M -$25.00 M -$9.45 M -$6.65 M
EBITDA Ratio 0 0 -555.51 -21.05 0
Operating Income Ratio 0 0 -513.96 -3.97 0
Total Other Income/Expenses Net -$419.00 K -$208.00 K -$2.29 M -$440.00 K -$1.16 M
Income Before Tax -$22.20 M -$29.20 M -$25.42 M $3.39 M -$7.93 M
Income Before Tax Ratio 0 0 -564.8 7.54 0
Income Tax Expense $14.00 K $16.00 K $11.00 K $11.00 K $4.00 K
Net Income -$22.14 M -$29.22 M -$25.43 M -$10.93 M -$7.94 M
Net Income Ratio 0 0 -565.04 -24.35 0
EPS -2.97 -1.73 -29.9 1.18 -0.22
EPS Diluted -2.97 -17.3 -29.9 1.18 -0.22
Weighted Average Shares Out $8.01 M $16.89 M $850.50 K $2.88 M $35.91 M
Weighted Average Shares Out Diluted $8.01 M $1.69 M $850.50 K $2.88 M $35.91 M
Link